Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

BioTime Appoints CFO

This article was originally published in Scrip

Executive Summary

BioTime Inc., a company focused on pluripotent stem cell technology, has appointed Russell Skibsted chief financial officer (CFO). Skibsted joins BioTime from Proove Biosciences where he was CFO and previously served as senior vice president (SVP), CFO and secretary of Aeolus Pharmaceuticals. Skibsted was also SVP and chief business officer of Spectrum Pharmaceuticals and CFO of Hana Biosciences.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register